{"id":92270,"date":"2026-10-16T06:06:10","date_gmt":"2026-10-16T10:06:10","guid":{"rendered":"https:\/\/hedgeco.net\/news\/10\/2026\/blackstone-agreed-to-sell-zo-skin-health-to-galderma-for-about-1-5-billion.html"},"modified":"2026-10-16T06:06:10","modified_gmt":"2026-10-16T10:06:10","slug":"blackstone-agreed-to-sell-zo-skin-health-to-galderma-for-about-1-5-billion","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/10\/2026\/blackstone-agreed-to-sell-zo-skin-health-to-galderma-for-about-1-5-billion.html","title":{"rendered":"Blackstone Agreed to Sell ZO Skin Health to Galderma for About $1.5 Billion:"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/hedgeco.net\/news\/wp-content\/uploads\/2026\/10\/2026-10-16-zo-hero.jpg\" alt=\"Blackstone Agreed to Sell ZO Skin Health to Galderma for About $1.5 Billion\" \/><\/p>\n<p>HedgeCo.Net \u2014 Galderma said it has signed an agreement to acquire 100% of ZO Skin Health from shareholders including funds managed by Blackstone Tactical Opportunities and the Obagi family for an enterprise value of $1.5 billion in an all-cash deal. Closing is expected in the fourth quarter of 2026 or early 2027, subject to regulatory approvals and customary conditions.<\/p>\n<p>Founded by dermatologist Dr. Zein Obagi and based in Irvine, California, ZO Skin Health sells clinical, regimen-based skincare through more than 16,500 physician, medical spa and online accounts in more than 40 countries. Galderma said ZO recorded about $330 million of net sales in the twelve months ended June 2026 across a portfolio of more than 40 products manufactured in the U.S.<\/p>\n<p>Galderma plans to fund the purchase with cash and bank financing and said the deal should be Core EPS-neutral in the first full year after closing. It expects to raise commercial investment in year one to support renewed growth from year two, and described ZO&#8217;s daily protocols as complementary to Alastin&#8217;s peri-procedure regenerative line within its Dermatological Skincare portfolio alongside Cetaphil.<\/p>\n<p>Blackstone Senior Managing Director Shary Moalemzadeh said the firm partnered with Dr. Obagi during a period when ZO more than doubled revenue. For private equity, the sale is a classic sponsor exit of a consumer-health specialty brand into a strategic consolidator with global dermatology distribution.<\/p>\n<p>Lazard and JP Morgan advised Galderma; Raymond James and Citi advised ZO and Blackstone. Investors will watch the regulatory path and whether Galderma can reaccelerate growth after the integration investment period.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>HedgeCo.Net \u2014 Galderma said it has signed an agreement to acquire 100% of ZO Skin Health from shareholders including funds managed by Blackstone Tactical Opportunities and the Obag\u2026 <a class=\"continue_reading_link btn btn-mini\" href=\"https:\/\/hedgeco.net\/news\/10\/2026\/blackstone-agreed-to-sell-zo-skin-health-to-galderma-for-about-1-5-billion.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":8,"featured_media":92269,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[8519,16908,16910,16905,16907,16909,16906],"class_list":["post-92270","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-private-equity","tag-blackstone","tag-dermatology","tag-exit","tag-galderma","tag-obagi","tag-physician-dispensed-skincare","tag-zo-skin-health"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/92270","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=92270"}],"version-history":[{"count":0,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/92270\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media\/92269"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=92270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=92270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=92270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}